source
- U.S. drug shortages stem from weak regulation, not China competition, says expertIn 2025 the United States faced 216 active drug shortages, limiting access to lifesaving medicines for patients. While the White House and national‑security officials have framed the problem as a…
- White House science blueprint pushes billions toward AI firms, away from university life-science researchThe White House Office of Science and Technology Policy released a report titled “Science: A New Golden Age.” The document outlines a new direction for U.S. federal science funding. The plan calls…